{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:13:39Z","timestamp":1792800819147,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":22,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key Laboratory of Chronic Deficiency Liver Disease of the State Administration of Traditional Chinese Medicine of the People's Republic of China","award":["20DZ2272200"],"award-info":[{"award-number":["20DZ2272200"]}],"id":[{"id":"https:\/\/ror.org\/003cpqh10","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Shanghai Key Specialty of Traditional Chinese Clinical Medicine","award":["shslczdzk01201"],"award-info":[{"award-number":["shslczdzk01201"]}]},{"name":"National Administration of Traditional Chinese Medicine","award":["zyyzdxk-2023060"],"award-info":[{"award-number":["zyyzdxk-2023060"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07587-9","type":"journal-article","created":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T17:29:09Z","timestamp":1769534949000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Achilles\u2019 heel of hepatocellular carcinoma: ginsenoside compound K as a novel GPX4 degrader promotes ferroptosis in hepatocellular carcinoma"],"prefix":"10.1186","volume":"24","author":[{"given":"Yulang","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peizhen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yipeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8103-7283","authenticated-orcid":false,"given":"Mingyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,27]]},"reference":[{"issue":"10","key":"7587_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD YANG","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management [J]. Nat Reviews Gastroenterol Hepatol. 2019;16(10):589\u2013604.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"1","key":"7587_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"D YOUNOSSI Z M, KOENIG A B, ABDELATIF","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes [J]. Hepatology (Baltimore MD). 2016;64(1):73\u201384.","journal-title":"Hepatology (Baltimore MD)"},{"issue":"1","key":"7587_CR3","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.cmet.2018.10.012","volume":"29","author":"S FEBBRAIO M A, REIBE","year":"2019","unstructured":"Febbraio MA, Reibe S. Preclinical models for studying NASH-Driven HCC: how useful are they? [J]. Cell Metabol. 2019;29(1):18\u201326.","journal-title":"Cell Metabol"},{"issue":"3","key":"7587_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s10555-023-10084-4","volume":"42","author":"Y WANG","year":"2023","unstructured":"Wang Y, Deng B. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers [J]. Cancer Metastasis Rev. 2023;42(3):629\u201352.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"7587_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41392-020-0187-x","volume":"5","author":"W TANG","year":"2020","unstructured":"Tang W, Chen Z, Zhang W, et al. The mechanisms of Sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects [J]. Signal Transduct Target Therapy. 2020;5(1):87.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"7587_CR6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41392-020-00264-x","volume":"5","author":"A HUANG","year":"2020","unstructured":"Huang A, Yang XR, Chung WY, et al. Targeted therapy for hepatocellular carcinoma [J]. Signal Transduct Target Therapy. 2020;5(1):146.","journal-title":"Signal Transduct Target Therapy"},{"issue":"4","key":"7587_CR7","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","volume":"78","author":"Y LIU","year":"2023","unstructured":"Liu Y, Xun Z. Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy [J]. J Hepatol. 2023;78(4):770\u201382.","journal-title":"J Hepatol"},{"key":"7587_CR8","doi-asserted-by":"crossref","unstructured":"Foerster F, Gairing SJ, Ilyas SI, et al. Emerging immunotherapy for HCC: a guide for hepatologists [J]. Hepatology. 2022;75(6):1604-26.","DOI":"10.1002\/hep.32447"},{"issue":"2","key":"7587_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J LI","year":"2020","unstructured":"Li J, Cao F, Yin HL, et al. Ferroptosis: past, present and future [J]. Cell Death Dis. 2020;11(2):88.","journal-title":"Cell Death Dis"},{"issue":"9","key":"7587_CR10","first-page":"2054","volume":"17","author":"X CHEN","year":"2021","unstructured":"Chen X, Li J, Kang R, et al. Ferroptosis: Mach Regul [J] Autophagy. 2021;17(9):2054\u201381.","journal-title":"Ferroptosis: Mach Regul [J] Autophagy"},{"issue":"1","key":"7587_CR11","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41420-024-01863-1","volume":"10","author":"Y JIANG","year":"2024","unstructured":"Jiang Y, Yu Y, Pan Z, et al. Ferroptosis: a new Hunter of hepatocellular carcinoma [J]. Cell Death Discov. 2024;10(1):136.","journal-title":"Cell Death Discov"},{"key":"7587_CR12","doi-asserted-by":"crossref","unstructured":"Jiang Y, Glandorff C, Sun M. GSH and ferroptosis: side-by-side partners in the fight against tumors [J]. Antioxid (Basel). 2024;13(6).","DOI":"10.3390\/antiox13060697"},{"issue":"6","key":"7587_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"JA DIXON S J, OLZMANN","year":"2024","unstructured":"Dixon SJ, Olzmann JA. The cell biology of ferroptosis [J]. Nat Rev Mol Cell Biol. 2024;25(6):424\u201342.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"7587_CR14","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X CHEN","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, et al. Broadening horizons: the role of ferroptosis in cancer [J]. Nat Reviews Clin Oncol. 2021;18(5):280\u201396.","journal-title":"Nat Reviews Clin Oncol"},{"issue":"9","key":"7587_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00432-024-05878-0","volume":"150","author":"Y JIANG","year":"2024","unstructured":"Jiang Y, Hui D, Pan Z, et al. Curcumin promotes ferroptosis in hepatocellular carcinoma via upregulation of ACSL4 [J]. J Cancer Res Clin Oncol. 2024;150(9):429.","journal-title":"J Cancer Res Clin Oncol"},{"key":"7587_CR16","doi-asserted-by":"publisher","first-page":"1438807","DOI":"10.3389\/fimmu.2024.1438807","volume":"15","author":"Y JIANG","year":"2024","unstructured":"Jiang Y, Sun M. SLC7A11: the Achilles heel of tumor? [J]. Front Immunol. 2024;15:1438807.","journal-title":"Front Immunol"},{"issue":"22","key":"7587_CR17","doi-asserted-by":"publisher","first-page":"7038","DOI":"10.1111\/febs.16059","volume":"289","author":"J LIU","year":"2022","unstructured":"Liu J, Kang R. Signaling pathways and defense mechanisms of ferroptosis [J]. FEBS J. 2022;289(22):7038\u201350.","journal-title":"FEBS J"},{"issue":"7","key":"7587_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G LEI","year":"2022","unstructured":"Lei G, Zhuang L. Targeting ferroptosis as a vulnerability in cancer [J]. Nat Rev Cancer. 2022;22(7):381\u201396.","journal-title":"Nat Rev Cancer"},{"key":"7587_CR19","doi-asserted-by":"crossref","unstructured":"Hirata Y, Ferreri C, Yamada Y, et al. Geometrical isomerization of arachidonic acid during lipid peroxidation interferes with ferroptosis [J]. Free Radic Biol Med. 2023;204:374\u201384.","DOI":"10.1016\/j.freeradbiomed.2023.05.026"},{"key":"7587_CR20","doi-asserted-by":"publisher","first-page":"1441105","DOI":"10.3389\/fphar.2024.1441105","volume":"15","author":"D XIE","year":"2024","unstructured":"Xie D, Jiang Y, Wang H, et al. Formononetin triggers ferroptosis in triple-negative breast cancer cells by regulating the mTORC1\/SREBP1\/SCD1 pathway [J]. Front Pharmacol. 2024;15:1441105.","journal-title":"Front Pharmacol"},{"issue":"1","key":"7587_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1186\/s12951-022-01663-8","volume":"20","author":"T LUO","year":"2022","unstructured":"Luo T, Wang Y, Wang J. Ferroptosis assassinates tumor [J]. J Nanobiotechnol. 2022;20(1):467.","journal-title":"J Nanobiotechnol"},{"issue":"9","key":"7587_CR22","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.molmed.2023.05.013","volume":"29","author":"W LI","year":"2023","unstructured":"Li W, Liang L, Liu S, et al. FSP1: a key regulator of ferroptosis [J]. Trends Mol Med. 2023;29(9):753\u201364.","journal-title":"Trends Mol Med"},{"issue":"7784","key":"7587_CR23","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","volume":"575","author":"K BERSUKER","year":"2019","unstructured":"Bersuker K, Hendricks JM, Li Z, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis [J]. Nature. 2019;575(7784):688\u201392.","journal-title":"Nature"},{"key":"7587_CR24","doi-asserted-by":"crossref","unstructured":"Jiang Y, Yu Y, Pan Z, et al. Ginsenoside RK1 induces ferroptosis in hepatocellular carcinoma cells through an FSP1-dependent pathway [J]. Pharmaceuticals (Basel). 2024;17(7).","DOI":"10.3390\/ph17070871"},{"key":"7587_CR25","doi-asserted-by":"publisher","first-page":"156239","DOI":"10.1016\/j.phymed.2024.156239","volume":"135","author":"X YAN","year":"2024","unstructured":"Yan X, Bai X, Sun G, et al. Ginsenoside compound K alleviates brain aging by inhibiting ferroptosis through modulation of the ASK1-MKK7-JNK signaling pathway [J]. Phytomedicine: Int J Phytotherapy Phytopharmacology. 2024;135:156239.","journal-title":"Phytomedicine: Int J Phytotherapy Phytopharmacology"},{"issue":"1","key":"7587_CR26","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s40001-024-02025-w","volume":"29","author":"X ZHAO","year":"2024","unstructured":"Zhao X, Yuan W. Ginsenoside Rh2 suppresses ferroptosis in ulcerative colitis by targeting specific protein 1 by upregulating microRNA-125a-5p [J]. Eur J Med Res. 2024;29(1):450.","journal-title":"Eur J Med Res"},{"key":"7587_CR27","doi-asserted-by":"publisher","first-page":"155289","DOI":"10.1016\/j.phymed.2023.155289","volume":"124","author":"Y HU","year":"2024","unstructured":"Hu Y, Lang Z, Li X, et al. Ginsenoside Rg3 promotes hepatic stellate cell ferroptosis by epigenetically regulating ACSL4 to suppress liver fibrosis progression [J]. Phytomedicine: Int J Phytotherapy Phytopharmacology. 2024;124:155289.","journal-title":"Phytomedicine: Int J Phytotherapy Phytopharmacology"},{"issue":"1","key":"7587_CR28","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12906-024-04492-4","volume":"24","author":"G ZHONG","year":"2024","unstructured":"Zhong G, Chen J, Li Y, et al. Ginsenoside Rg3 attenuates myocardial ischemia\/reperfusion-induced ferroptosis via the keap1\/Nrf2\/GPX4 signaling pathway [J]. BMC Complement Med Ther. 2024;24(1):247.","journal-title":"BMC Complement Med Ther"},{"issue":"10\u201311","key":"7587_CR29","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s12272-024-01516-y","volume":"47","author":"Z YE","year":"2024","unstructured":"Ye Z, Ding J, Huang J, et al. Ginsenoside Rg3 activates the immune function of CD8\u2009+\u2009T cells via circFOXP1-miR-4477a-PD-L1 axis to induce ferroptosis in gallbladder cancer [J]. Arch Pharm Res. 2024;47(10\u201311):793\u2013811.","journal-title":"Arch Pharm Res"},{"issue":"3","key":"7587_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1039\/c0np00057d","volume":"28","author":"S QI L W, WANG C Z, YUAN C","year":"2011","unstructured":"Qi L W, Wang CZ, Yuan CS. Isolation and analysis of ginseng: advances and challenges [J]. Nat Prod Rep. 2011;28(3):467\u201395.","journal-title":"Nat Prod Rep"},{"issue":"5","key":"7587_CR31","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1080\/10408398.2021.1952159","volume":"63","author":"P CHOPRA","year":"2023","unstructured":"Chopra P, Chhillar H, Kim YJ, et al. Phytochemistry of ginsenosides: recent advancements and emerging roles [J]. Crit Rev Food Sci Nutr. 2023;63(5):613\u201340.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"7587_CR32","doi-asserted-by":"publisher","first-page":"120698","DOI":"10.1016\/j.lfs.2022.120698","volume":"304","author":"J ZHANG","year":"2022","unstructured":"Zhang J, Tong Y, Lu X, et al. A derivant of ginsenoside CK and its inhibitory effect on hepatocellular carcinoma [J]. Life Sci. 2022;304:120698.","journal-title":"Life Sci"},{"key":"7587_CR33","doi-asserted-by":"crossref","unstructured":"Zhang J, Ma X, Fan D. Ginsenoside CK inhibits hypoxia-induced epithelial-mesenchymal transformation through the HIF-1\u03b1\/NF-\u03baB feedback pathway in hepatocellular carcinoma [J]. Foods (Basel). 2021;10(6).","DOI":"10.3390\/foods10061195"},{"key":"7587_CR34","doi-asserted-by":"crossref","unstructured":"Zhang J, Ma X, Fan D. Ginsenoside CK ameliorates hepatic lipid accumulation via activating the LKB1\/AMPK pathway in vitro and in vivo [J]. Food Funct. 2022;13(3):1153\u201367.","DOI":"10.1039\/D1FO03026D"},{"key":"7587_CR35","doi-asserted-by":"publisher","first-page":"1461022","DOI":"10.3389\/froh.2024.1461022","volume":"5","author":"A ANTONELLI","year":"2024","unstructured":"Antonelli A, Battaglia AM, Sacco A, et al. Ferroptosis and oral squamous cell carcinoma: connecting the Dots to move forward [J]. Front Oral Health. 2024;5:1461022.","journal-title":"Front Oral Health"},{"issue":"9","key":"7587_CR36","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.7150\/ijbs.111228","volume":"21","author":"L PETRIAGGI","year":"2025","unstructured":"Petriaggi L, Giorgio E, Bulotta S, et al. Acute exposure to cadmium triggers NCOA4-Mediated ferritinophagy and ferroptosis in Never-Smokers oral cancer cells [J]. Int J Biol Sci. 2025;21(9):4131\u201352.","journal-title":"Int J Biol Sci"},{"key":"7587_CR37","doi-asserted-by":"publisher","first-page":"115101","DOI":"10.1016\/j.bcp.2022.115101","volume":"202","author":"B ZHANG","year":"2022","unstructured":"Zhang B, Fu R, Duan Z, et al. Ginsenoside CK induces apoptosis in triple-negative breast cancer cells by targeting glutamine metabolism [J]. Biochem Pharmacol. 2022;202:115101.","journal-title":"Biochem Pharmacol"},{"key":"7587_CR38","doi-asserted-by":"publisher","first-page":"977539","DOI":"10.3389\/fphar.2022.977539","volume":"13","author":"Y WAN","year":"2022","unstructured":"Wan Y, Liu D, Xia J, et al. Ginsenoside CK, rather than Rb1, possesses potential chemopreventive activities in human gastric cancer via regulating PI3K\/AKT\/NF-\u03baB signal pathway [J]. Front Pharmacol. 2022;13:977539.","journal-title":"Front Pharmacol"},{"key":"7587_CR39","doi-asserted-by":"crossref","unstructured":"Yin Q, Chen H, Ma RH, et al. Ginsenoside CK induces apoptosis of human cervical cancer HeLa cells by regulating autophagy and endoplasmic reticulum stress [J]. Food Funct. 2021;12(12):5301\u201316.","DOI":"10.1039\/D1FO00348H"},{"issue":"7","key":"7587_CR40","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1002\/ptr.7087","volume":"35","author":"N SHIN","year":"2021","unstructured":"Shin N, Lee HJ, Sim DY, et al. Apoptotic effect of compound K in hepatocellular carcinoma cells via Inhibition of Glycolysis and Akt\/mTOR\/c-Myc signaling [J]. Phytother Res. 2021;35(7):3812\u201320.","journal-title":"Phytother Res"},{"issue":"4","key":"7587_CR41","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X JIANG","year":"2021","unstructured":"Jiang X, Stockwell BR, Conradm. Ferroptosis: mechanisms, biology and role in disease [J]. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"Pt 2","key":"7587_CR42","doi-asserted-by":"publisher","first-page":"145472","DOI":"10.1016\/j.ijbiomac.2025.145472","volume":"319","author":"Y JIANG","year":"2025","unstructured":"Jiang Y, Liu X. The mist of ferroptosis: the Orpheus journey of mitochondria - Exploring the symphony of cell fate [J]. Int J Biol Macromol. 2025;319(Pt 2):145472.","journal-title":"Int J Biol Macromol"},{"key":"7587_CR43","doi-asserted-by":"crossref","unstructured":"Zheng Y, Wang Y, Lu Z, et al. PGAM1 inhibition promotes HCC ferroptosis and synergizes with anti-PD-1 immunotherapy [J]. Adv Sci (Weinh). 2023;10(29):e2301928.","DOI":"10.1002\/advs.202301928"},{"key":"7587_CR44","doi-asserted-by":"crossref","unstructured":"Liao P, Wang W, Wang W, et al. CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4 [J]. Cancer Cell. 2022;40(4):365\u2009\u2013\u200978.e6.","DOI":"10.1016\/j.ccell.2022.02.003"},{"key":"7587_CR45","doi-asserted-by":"crossref","unstructured":"Zhou Y. Rong Y. Hypoxic natural killer cells-derived HIF-1\u03b1-containing exosomes inhibit cellular senescence and apoptosis in neurocytes to ameliorate Alzheimer\u2019s disease by eliminating oxidative damages [J]. Mol Neurobiol. 2025.","DOI":"10.1007\/s12035-025-05111-0"},{"issue":"1","key":"7587_CR46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13046-025-03404-9","volume":"44","author":"J WANG","year":"2025","unstructured":"Wang J, Jia Y, Liu T, et al. Tumor cell-intrinsic BIN1 deficiency promotes the immunosuppression and impedes ferroptosis of non-small cell lung cancer via G3BP1-mediated degradation of STAT1 [J]. J Experimental Clin Cancer Research: CR. 2025;44(1):141.","journal-title":"J Experimental Clin Cancer Research: CR"},{"key":"7587_CR47","doi-asserted-by":"publisher","first-page":"820781","DOI":"10.3389\/fcell.2022.820781","volume":"10","author":"J LI","year":"2022","unstructured":"Li J, Zhang N, Li M, et al. The emerging role of OTUB2 in diseases: from cell signaling pathway to physiological function [J]. Front Cell Dev Biology. 2022;10:820781.","journal-title":"Front Cell Dev Biology"},{"issue":"1","key":"7587_CR48","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.molcel.2018.10.030","volume":"73","author":"Z ZHANG","year":"2019","unstructured":"Zhang Z, Du J, Wang S, et al. OTUB2 promotes cancer metastasis via Hippo-Independent activation of YAP and TAZ [J]. Mol Cell. 2019;73(1):7\u2013e217.","journal-title":"Mol Cell"},{"issue":"1","key":"7587_CR49","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/s41388-021-02071-2","volume":"41","author":"S YU","year":"2022","unstructured":"Yu S, Zang W, Qiu Y, et al. Deubiquitinase OTUB2 exacerbates the progression of colorectal cancer by promoting PKM2 activity and Glycolysis [J]. Oncogene. 2022;41(1):46\u201356.","journal-title":"Oncogene"},{"key":"7587_CR50","doi-asserted-by":"crossref","unstructured":"Wu Y, Mohd Sani SB, Peng K, et al. Research progress of the Otubains subfamily in hepatocellular carcinoma [J]. Biomed Pharmacother. 2024;179:117348.","DOI":"10.1016\/j.biopha.2024.117348"},{"issue":"3","key":"7587_CR51","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12195-022-00720-4","volume":"15","author":"G HU","year":"2022","unstructured":"Hu G, Yang J, Zhang H, et al. OTUB2 promotes proliferation and migration of hepatocellular carcinoma cells by PJA1 deubiquitylation [J]. Cell Mol Bioeng. 2022;15(3):281\u201392.","journal-title":"Cell Mol Bioeng"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07587-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07587-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07587-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T14:00:26Z","timestamp":1771423226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07587-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7587"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07587-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,27]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the author utilized the DeepSeek tool to enhance text readability and linguistic fluency. Following the use of this tool, the author conducted a comprehensive review and editing of the refined content based on actual requirements and ultimately assumes full responsibility for the content of the published article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI in scientific writing"}},{"value":"The authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"277"}}